Yes, rapid escalation can increase the risk of nausea, vomiting, dehydration, and in rare cases, pancreatitis or gallbladder issues
Nutrients 10 , 1203 (2018)
These predispositions do not predict exact medication outcomes but support a more informed, provider-guided treatment selection conversation tailored to your metabolic biology
People who have come off GLP-1 drugs are a target market for Israeli start-up Lembas
When GLP-1 medications slow intestinal transit, your colon has more time to absorb water from stool
Future translational research should aim to define the carnitine-responsive phenotype using integrated approaches, including serum acylcarnitine profiling, quantitative MRI of muscle fat, and CPT1A genotyping to enable precise patient stratification